Coronavirus News

Press Release: October 5, 2021
EUROIMMUN Anti-SARS-CoV-2 S1 Curve ELISA Receives FDA Emergency Use Authorization

Press Release: April 21, 2020
Quest Diagnostics Begins to Perform COVID-19 Antibody Testing

Press Release: May 5, 2020
FDA Provides Emergency Use Authorization to PerkinElmer for Serological Test to Identify COVID-19 Antibodies

Press Release: May 7, 2020
Direct-to-Consumer COVID-19 Antibody Test Available Through Sonora Quest Laboratories

Press Release: May 13, 2020
ARUP Offers Second COVID-19 Antibody Test to Providers Nationwide

Press Release, May 14, 2020
LabCorp Launches Return to Work Services for Employers

Media: ABC News
Largest antibody study could answer crucial coronavirus questions

Coronavirus Resources

Letter of Authorization

Instructions for Use

Fact Sheet for Healthcare Providers

Fact Sheets for Recipients

Publications

Padoan et al. IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study. Clin Chim Acta. 2020 Apr 25;507:164-166. doi: 10.1016/j.cca.2020.04.026.

GeurtsvanKessel et al. Towards the next phase: evaluation of serological assays for diagnostics and exposure assessment. Preprint medRxiv. 2020

Streeck et al. Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event. 2020

Lippi et al. Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays. Clin Chem Lab Med. 2020 Apr 16. pii: /j/cclm.ahead-of-print/cclm-2020-0473/cclm-2020-0473.xml. doi: 10.1515/cclm-2020-0473.

Kohmer et al. Clinical performance of SARS-CoV-2 IgG antibody tests and potential protective immunity. bioRxiv. 2020

Montesinos et al. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies. J Clin Virol. 2020